as 09-06-2024 4:00pm EST
Founded: | 1947 | Country: | United States |
Employees: | N/A | City: | WILMINGTON |
Market Cap: | N/A | IPO Year: | 2000 |
Target Price: | $226.27 | AVG Volume (30 days): | 663.6K |
Analyst Decision: | Buy | Number of Analysts: | 13 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 8.35 | EPS Growth: | -11.52 |
52 Week Low/High: | $161.65 - $275.00 | Next Earning Date: | 08-07-2024 |
Revenue: | $4,077,776,000 | Revenue Growth: | -2.41% |
Revenue Growth (this year): | -2.26% | Revenue Growth (next year): | 3.17% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
FOSTER JAMES C | CRL | Chairman, President and CEO | Aug 1 '24 | Sell | $250.00 | 25,000 | $6,250,000.00 | 188,251 |
CRL Breaking Stock News: Dive into CRL Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Insider Monkey
a day ago
MT Newswires
3 days ago
Business Wire
3 days ago
Business Wire
4 days ago
Simply Wall St.
6 days ago
Insider Monkey
11 days ago
Medical Device Network
20 days ago
The information presented on this page, "CRL Charles River Laboratories International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.